Auswahl wichtiger Veröffentlichungen der letzten Jahre
Arbeitsgruppe Löscher:
Gernert, M., M. Hamann, M. Bennay, W. Löscher, and A. Richter
Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased
basal
ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia.
J. Neurosci. 20: 7052-7058,
2000
Altrock, W.D., S. tom Dieck, M. Sokolov, A.C. Meyer, A. Sigler, C. Brakebusch,
R. Fassler, K. Richter, T.M. Boeckers, H. Potschka, C. Brandt, W. Löscher, D.
Grimberg,
T. Dresbach, A. Hempelmann, H. Hassan, D. Balschun, J.U. Frey,
J.H. Brandstatter, C.C. Garner, C. Rosenmund, and E.D. Gundelfinger
Functional inactivation of a fraction of excitatory synapses in mice deficient for
the active zone protein bassoon.
Neuron 37: 787-800, 2003
Brandt, C.,
H. Potschka, W. Löscher, and U. Ebert
N-methyl-D-aspartate receptor blockade after status epilepticus protects against
limbic
brain damage but not against epilepsy in the kainate model of temporal
lobe
epilepsy.
Neuroscience 118: 727-40,
2003
Rogawski, M. A. and W. Löscher:
The neurobiology of antiepileptic drugs.
Nature Rev. Neurosci., 5: 553-564, 2004
Rogawski, M. A. and W. Löscher:
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.
Nature Med., 10: 685-692, 2004
Volk, H. A. and W. Löscher:
Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain
expression of P-glycoprotein compared with rats with drug-responsive seizures.
Brain, 128, 1358-1368,
2005
Löscher, W. and H. Potschka:
Drug resistance in brain diseases and the role of drug efflux transporters.
Nature Rev. Neurosci., 6: 591-602, 2005
Brandt,
C., K. Bethmann, A. M. Gastens, and W. Löscher:
The multidrug transporter hypothesis of drug resistance in epilepsy:
proof-of-principle in a rat model of temporal lobe epilepsy.
Neurobiol. Dis., 24: 202-211, 2006

Arbeitsgruppe Kietzmann / Bäumer:
Immunpharmakologie
Bäumer W., U. Seegers, M. Braun, T. Tschernig and M. Kietzmann.
TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis.
Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokines.
Br. J. Dermatol., 151: 823-830, 2004
Bäumer, W., B. Sülzle, H. Weigt, V.C. De Vries, M. Hecht, T. Tschernig and M. Kietzmann
Cilomilast, tacrolimus, and rapamycin, modulate dendritic cell function in the
elicitation phase of allergic contact dermatitis.
Br. J. Dermatol., 153: 136-144, 2005
Bäumer, W., J. Hoppmann and C. Rundfeldt
Highly selective PDE4 inhibitors for the treatment of allergic diseases and psoriasis.
Inflammation & Allergy-Drug Targets, 6: 17-26, 2007
In-vitro-Modelle
Kietzmann, M., W. Löscher, D. Arens, P. Maass and D. Lubach
The isolated perfused bovine udder as an in vitro model of percutaneous drug absorption.
Skin viability and percutaneous absorption of dexamethasone, benzoyl peroxide, and etofenamate.
J. Pharmacol. Toxicol.
Methods, 30: 75-84, 1993
Ehinger, A.M., H. Schmidt, M. Kietzmann M
Tissue distribution of cefquinome after intramammary and “systemic” administration in the isolated perfused bovine udder.
Vet. J. 172: 147-153, 2006
Braun, M. and M. Kietzmann
Ischaemia-reperfusion injury in the isolated haemoperfused bovine uterus: an in vitro model of acute inflammation.
Altern. Lab. Anim., 32: 69-77, 2004
Vietmeier, J., F. Niedorf , W. Bäumer, C. Martin, E. Deegen, B. Ohnesorge and M. Kietzmann
Reactivity of equine airways--a study on precision-cut lung slices.
Vet. Res. Comm., 31: 611-619, 2007
Dermale Resorption
Schäfer-Korting M., U. Bock, A. Gamer, A. Haberland, E. Haltner-Ukomadu, M. Kaca, H. Kamp,
M. Kietzmann, H.C. Korting, H.U. Krächter, C.M. Lehr, M. Liebsch, A. Mehling, F. Netzlaff,
F. Niedorf, M.K. Rübbelke, U. Schäfer, E. Schmidt, S. Schreiber, K.R. Schröder, H. Spielmann and A.Vuia
Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study.
Altern. Lab. Anim., 34: 283-294, 2006
Netzlaff F., U.F. Schaefer, C.M. Lehr, P. Meiers, J. Stahl, M. Kietzmann and F. Niedorf
Comparison of bovine udder skin with human and porcine skin in percutaneous permeation experiments.
Altern Lab Anim.,
34: 499-513, 2006
Sonstiges
Braun,
M., K. Lelieur, M. Kietzmann
Purinergic substances promote murine keratinocyte proliferation and enhance impaired wound healing.
Wound Rep. Reg., 14, 153-162, 2006
Tansakul N., F. Niedorf, M. Kietzmann
A sulfadimidine model to evaluate pharmacokinetics and residues at various concentrations in laying hen.
Food Addit. Contam. 24,
598-604, 2007
Machnik M., I. Hegger, M. Kietzmann, M. Thevis, S. Guddat, W. Schänzer
Pharmacokinetics of altrenogest in horses.
J. vet. Pharmacol. Therap., 30, 86-90,
2007
